Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma

Tammy I. Kang(Texas Children's Hospital), John M. Maris(Children's Hospital of Philadelphia), Audrey E. Evans(Purdue University West Lafayette), Sydney Heyman, Mark Hickeson(Children's Hospital of Philadelphia), Patricia Brophy(Children's Hospital of Philadelphia), Martin Charron(Children's Hospital of Philadelphia)
Journal of Pediatric Hematology/Oncology
September 26, 2003
10.1097/00043426-200310000-00005
Cited by 64

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583